Veterans’ Support Amendment Regulations (No 6) 2021

  • latest version but not yet in force

2021/437

Coat of Arms of New Zealand

Veterans’ Support Amendment Regulations (No 6) 2021

Cindy Kiro, Governor-General

Order in Council

At Wellington this 20th day of December 2021

Present:
Her Excellency the Governer-General in Council

These regulations are made under section 265 of the Veterans’ Support Act 2014

(a)

on the advice and with the consent of the Executive Council; and

(b)

on the recommendation of the Minister for Veterans made in accordance with section 23 of that Act.

Regulations

1 Title

These regulations are the Veterans’ Support Amendment Regulations (No 6) 2021.

2 Commencement

These regulations come into force on 20 January 2022.

3 Principal regulations

These regulations amend the Veterans’ Support Regulations 2014.

4 Schedule 1 amended

Amend Schedule 1 as set out in Schedule 1 of these regulations.

5 Schedule 2A amended

Amend Schedule 2A as set out in Schedule 2 of these regulations.

Schedule 1 Schedule 1 amended

r 4

In the item relating to carpal tunnel syndrome,—

(a)

replace “7/2013” with “93/2021”; and

(b)

replace “8/2013” with “94/2021”.

In the item relating to chronic fatigue syndrome,—

(a)

replace “11/2014” with “105/2021”; and

(b)

replace “12/2014” with “106/2021”.

In the item relating to chronic gastritis and chronic gastropathy,—

(a)

replace “25/2013” with “101/2021”; and

(b)

replace “26/2013” with “102/2021”.

Replace the item relating to dental pulp and apical disease with:

dental pulp and periapical disease99/2021100/2021

In the item relating to essential thrombocythaemia,—

(a)

replace “15/2013” with “91/2021”; and

(b)

replace “16/2013” with “92/2021”.

In the item relating to familial adenomatous polyposis,—

(a)

replace “39/2013” with “77/2021”; and

(b)

replace “40/2013” with “78/2021”.

In the item relating to fibromyalgia,—

(a)

replace “13/2014” with “107/2021”; and

(b)

replace “14/2014” with “108/2021”.

In the item relating to fibrosing interstitial lung disease,—

(a)

replace “53/2013” with “85/2021”; and

(b)

replace “54/2013” with “86/2021”.

In the item relating to malignant neoplasm of the pancreas,—

(a)

replace “73/2013” with “103/2021”; and

(b)

replace “74/2013” with “104/2021”.

In the item relating to myeloma,—

(a)

replace “69/2012” with “95/2021”; and

(b)

replace “70/2012” with “96/2021”.

In the item relating to polycythaemia vera,—

(a)

replace “11/2013” with “87/2021”; and

(b)

replace “12/2013” with “88/2021”.

In the item relating to primary myelofibrosis,—

(a)

replace “17/2013” with “89/2021”; and

(b)

replace “18/2013” with “90/2021”.

In the item relating to solar keratosis,—

(a)

replace “73/2012” with “79/2021”; and

(b)

replace “74/2012” with “80/2021”.

Schedule 2 Schedule 2A amended

r 5

Insert in their appropriate alphabetical order:

hypogonadism
mesenteric panniculitis
pure red cell aplasia
transverse myelitis

Michael Webster,
Clerk of the Executive Council.

Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.

These regulations, which come into force on 20 January 2022, amend the Veterans’ Support Regulations 2014 (the principal regulations).

Regulation 4 and Schedule 1 amend Schedule 1 of the principal regulations, which lists the Australian statements of principles (the statements) that apply to specified medical conditions for the purposes of the Veterans’ Support Act 2014 (the Act). The amendments—

  • replace the name of the condition dental pulp and apical disease in order to reflect the statements (the new name is dental pulp and periapical disease):

  • update references to the statements.

Regulation 5 and Schedule 2 amend Schedule 2A of the principal regulations, which lists accepted late-onset conditions for the purposes of the definition of accepted late-onset condition in section 7 of the Act. The amendment inserts 4 new accepted late-onset conditions (hypogonadism, mesenteric panniculitis, pure red cell aplasia, and transverse myelitis).

Issued under the authority of the Legislation Act 2019.

Date of notification in Gazette: 22 December 2021.

These regulations are administered by the New Zealand Defence Force.